Copyright Reports & Markets. All rights reserved.

Global Microneedle Drug Delivery Systems Market Growth 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global Microneedle Drug Delivery Systems Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Microneedle Drug Delivery Systems Consumption 2014-2024
        • 2.1.2 Microneedle Drug Delivery Systems Consumption CAGR by Region
      • 2.2 Microneedle Drug Delivery Systems Segment by Type
        • 2.2.1 Hollow Microneedle Technology
        • 2.2.2 Solid Microneedle Technology
        • 2.2.3 Dissolving Microneedles Technology
      • 2.3 Microneedle Drug Delivery Systems Consumption by Type
        • 2.3.1 Global Microneedle Drug Delivery Systems Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Microneedle Drug Delivery Systems Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Microneedle Drug Delivery Systems Sale Price by Type (2014-2019)
      • 2.4 Microneedle Drug Delivery Systems Segment by Application
        • 2.4.1 Drug Delivery
        • 2.4.2 Vaccine Delivery
        • 2.4.3 Other
      • 2.5 Microneedle Drug Delivery Systems Consumption by Application
        • 2.5.1 Global Microneedle Drug Delivery Systems Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Microneedle Drug Delivery Systems Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Microneedle Drug Delivery Systems Sale Price by Application (2014-2019)

      3 Global Microneedle Drug Delivery Systems by Players

      • 3.1 Global Microneedle Drug Delivery Systems Sales Market Share by Players
        • 3.1.1 Global Microneedle Drug Delivery Systems Sales by Players (2017-2019)
        • 3.1.2 Global Microneedle Drug Delivery Systems Sales Market Share by Players (2017-2019)
      • 3.2 Global Microneedle Drug Delivery Systems Revenue Market Share by Players
        • 3.2.1 Global Microneedle Drug Delivery Systems Revenue by Players (2017-2019)
        • 3.2.2 Global Microneedle Drug Delivery Systems Revenue Market Share by Players (2017-2019)
      • 3.3 Global Microneedle Drug Delivery Systems Sale Price by Players
      • 3.4 Global Microneedle Drug Delivery Systems Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Microneedle Drug Delivery Systems Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Microneedle Drug Delivery Systems Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Microneedle Drug Delivery Systems by Regions

      • 4.1 Microneedle Drug Delivery Systems by Regions
        • 4.1.1 Global Microneedle Drug Delivery Systems Consumption by Regions
        • 4.1.2 Global Microneedle Drug Delivery Systems Value by Regions
      • 4.2 Americas Microneedle Drug Delivery Systems Consumption Growth
      • 4.3 APAC Microneedle Drug Delivery Systems Consumption Growth
      • 4.4 Europe Microneedle Drug Delivery Systems Consumption Growth
      • 4.5 Middle East & Africa Microneedle Drug Delivery Systems Consumption Growth

      5 Americas

      • 5.1 Americas Microneedle Drug Delivery Systems Consumption by Countries
        • 5.1.1 Americas Microneedle Drug Delivery Systems Consumption by Countries (2014-2019)
        • 5.1.2 Americas Microneedle Drug Delivery Systems Value by Countries (2014-2019)
      • 5.2 Americas Microneedle Drug Delivery Systems Consumption by Type
      • 5.3 Americas Microneedle Drug Delivery Systems Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Microneedle Drug Delivery Systems Consumption by Countries
        • 6.1.1 APAC Microneedle Drug Delivery Systems Consumption by Countries (2014-2019)
        • 6.1.2 APAC Microneedle Drug Delivery Systems Value by Countries (2014-2019)
      • 6.2 APAC Microneedle Drug Delivery Systems Consumption by Type
      • 6.3 APAC Microneedle Drug Delivery Systems Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Microneedle Drug Delivery Systems by Countries
        • 7.1.1 Europe Microneedle Drug Delivery Systems Consumption by Countries (2014-2019)
        • 7.1.2 Europe Microneedle Drug Delivery Systems Value by Countries (2014-2019)
      • 7.2 Europe Microneedle Drug Delivery Systems Consumption by Type
      • 7.3 Europe Microneedle Drug Delivery Systems Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Microneedle Drug Delivery Systems by Countries
        • 8.1.1 Middle East & Africa Microneedle Drug Delivery Systems Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Microneedle Drug Delivery Systems Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Microneedle Drug Delivery Systems Consumption by Type
      • 8.3 Middle East & Africa Microneedle Drug Delivery Systems Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.2 Microneedle Drug Delivery Systems Distributors
      • 10.3 Microneedle Drug Delivery Systems Customer

      11 Global Microneedle Drug Delivery Systems Market Forecast

      • 11.1 Global Microneedle Drug Delivery Systems Consumption Forecast (2019-2024)
      • 11.2 Global Microneedle Drug Delivery Systems Forecast by Regions
        • 11.2.1 Global Microneedle Drug Delivery Systems Forecast by Regions (2019-2024)
        • 11.2.2 Global Microneedle Drug Delivery Systems Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Microneedle Drug Delivery Systems Forecast by Type
      • 11.8 Global Microneedle Drug Delivery Systems Forecast by Application

      12 Key Players Analysis

      • 12.1 3M
        • 12.1.1 Company Details
        • 12.1.2 Microneedle Drug Delivery Systems Product Offered
        • 12.1.3 3M Microneedle Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 3M News
      • 12.2 Zosano Pharma
        • 12.2.1 Company Details
        • 12.2.2 Microneedle Drug Delivery Systems Product Offered
        • 12.2.3 Zosano Pharma Microneedle Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Zosano Pharma News
      • 12.3 Becton-Dickinson（BD）Technologies
        • 12.3.1 Company Details
        • 12.3.2 Microneedle Drug Delivery Systems Product Offered
        • 12.3.3 Becton-Dickinson（BD）Technologies Microneedle Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Becton-Dickinson（BD）Technologies News
      • 12.4 Nanopass Technologies
        • 12.4.1 Company Details
        • 12.4.2 Microneedle Drug Delivery Systems Product Offered
        • 12.4.3 Nanopass Technologies Microneedle Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Nanopass Technologies News
      • 12.5 Corium
        • 12.5.1 Company Details
        • 12.5.2 Microneedle Drug Delivery Systems Product Offered
        • 12.5.3 Corium Microneedle Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Corium News
      • 12.6 Valeritas
        • 12.6.1 Company Details
        • 12.6.2 Microneedle Drug Delivery Systems Product Offered
        • 12.6.3 Valeritas Microneedle Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Valeritas News
      • 12.7 Nitto
        • 12.7.1 Company Details
        • 12.7.2 Microneedle Drug Delivery Systems Product Offered
        • 12.7.3 Nitto Microneedle Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Nitto News
      • 12.8 Microdermics
        • 12.8.1 Company Details
        • 12.8.2 Microneedle Drug Delivery Systems Product Offered
        • 12.8.3 Microdermics Microneedle Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Microdermics News
      • 12.9 TheraJect, Inc
        • 12.9.1 Company Details
        • 12.9.2 Microneedle Drug Delivery Systems Product Offered
        • 12.9.3 TheraJect, Inc Microneedle Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 TheraJect, Inc News
      • 12.10 Vaxxas
        • 12.10.1 Company Details
        • 12.10.2 Microneedle Drug Delivery Systems Product Offered
        • 12.10.3 Vaxxas Microneedle Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 Vaxxas News
      • 12.11 Lohmann Therapie-Systeme AG

      13 Research Findings and Conclusion

      Microneedle drug delivery systems usually include hollow microneedle and solid microneedle technology, offer patient-friendly delivery solutions for vaccines or difficult-to-deliver biologics for particularly needle-phobic patients.
      Intradermal drug delivery is increasingly recognized as a potential solution to many of the challenges faced by new and existing medicines. Intradermal dosing provides the opportunity to more effectively administer agents such as small molecules, biologics, and vaccines, allowing for improved bioavailability. Nonetheless, the widespread use of this route of administration continues to be limited by technical challenges in the performing of intradermal injections, which requires specialized training and has poor reproducibility.
      Microneedles are a rapidly growing technology developed to solve issues surrounding intradermal drug administration. While many microneedle platforms have been developed over nearly 2 decades, the issues and concerns remain largely the same.

      According to this study, over the next five years the Microneedle Drug Delivery Systems market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Microneedle Drug Delivery Systems business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares, and growth opportunities of Microneedle Drug Delivery Systems market by product type, application, key manufacturers and key regions and countries.

      This study considers the Microneedle Drug Delivery Systems value and volume generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
      Hollow Microneedle Technology
      Solid Microneedle Technology
      Dissolving Microneedles Technology
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
      Drug Delivery
      Vaccine Delivery
      Other

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      3M
      Zosano Pharma
      Becton-Dickinson（BD）Technologies
      Nanopass Technologies
      Corium
      Valeritas
      Nitto
      Microdermics
      TheraJect, Inc
      Vaxxas
      Lohmann Therapie-Systeme AG

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Microneedle Drug Delivery Systems consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Microneedle Drug Delivery Systems market by identifying its various subsegments.
      Focuses on the key global Microneedle Drug Delivery Systems manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Microneedle Drug Delivery Systems with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the consumption of Microneedle Drug Delivery Systems submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now